Advanced search
Publication Cover
Leukemia & Lymphoma Volume 63, 2022 - Issue 12
Submit an article Journal homepage
102
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor

Early CD49d downmodulation in chronic lymphocytic leukemia patients treated front-line with ibrutinib plus rituximab predicts long-term response

Nadia Peraginea Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, ItalyView further author information
,
Maria Stefania De Proprisa Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, ItalyView further author information
,
Stefania Intoppaa Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, ItalyView further author information
,
Maria Laura Milania Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, ItalyView further author information
,
Francesca Romana Mauroa Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, ItalyORCID Iconhttps://orcid.org/0000-0003-2425-9474View further author information
ORCID Icon,
Antonio Cuneob Hematology, Department of Medical Sciences, University of Ferrara, Ferrara, ItalyView further author information
,
Gian Matteo Rigolinb Hematology, Department of Medical Sciences, University of Ferrara, Ferrara, ItalyView further author information
,
Ilaria Del Giudicea Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, ItalyORCID Iconhttps://orcid.org/0000-0001-6864-9533View further author information
ORCID Icon,
Robin Foàa Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, ItalyCorrespondence[email protected]
View further author information
&
Anna Guarinic Department of Molecular Medicine, Sapienza University, Rome, ItalyView further author information
 show all
Pages 2982-2986 | Received 10 Mar 2022, Accepted 16 Jul 2022, Published online: 01 Aug 2022
 
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days
Click to increase image sizeClick to decrease image sizeFree first page

Acknowledgements

Trial registration: clinicaltrials.gov identifier NCT02232386.

Author contributions

NP, RF, and AG designed the research study; MSDP, SI, and MLM carried out the lab work; MSDP, FRM, AC, GMR, and IDG analyzed the data; NP, RF, and AG wrote the paper.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Additional information

Funding

This work was supported by Associazione Italiana Ricerca sul Cancro (AIRC), Special 5x1000 Program Metastases (21198), Milan (Italy) to RF. SI and MLM were supported by ROMAIL ONLUS.

Log in via your institution

Access through your institution

Log in to Taylor & Francis Online

Restore content access

Restore content access for purchases made as guest
Purchase options * Save for later

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 1,065.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.